Fulgent Genetics Provides Update on Testing for Covid-19
End-to-end testing enables Fulgent to more efficiently manage the demand it is seeing for both its RT-PCR and next-generation sequencing tests for Covid-19.
Read MorePosted by | Apr 15, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
End-to-end testing enables Fulgent to more efficiently manage the demand it is seeing for both its RT-PCR and next-generation sequencing tests for Covid-19.
Read MorePosted by | Apr 14, 2020 | Emerging & Zoonotic Diseases, Infectious Diseases |
Initially Biodesix is receiving samples for covid-19 testing from local health systems, hospitals, and clinics in Colorado.
Read MorePosted by | Apr 14, 2020 | Biochemicals & Chemical Reagents, Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases, Molecular Diagnostics |
The kit is particularly suitable for total nucleic acid extraction for detecting SARS-CoV-2, the virus that causes covid-19.
Read MorePosted by | Apr 13, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
Sema4 is processing samples in its clinical laboratory, which can analyze 6,000 covid-19 tests per week and return results within 24 to 48 hours.
Read MorePosted by | Apr 13, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
Performance Insight can now populate all the required covid-19 testing data directly into the assigned template and automatically email it to HHS and FEMA.
Read More